LXRP - Lexaria Bioscience Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue2018-08-312017-08-312016-08-312015-08-31
Total Revenue433.28763.63940.71814.702
Cost of Revenue38.15198.36189.65529.883
Gross Profit395.136-34.722-48.937-15.181
Operating Expenses
Research Development492.86454.1859.024146.466
Selling General and Administrative6,512.9621,741.3741,154.8451,744.987
Non Recurring----
Others--2.3743.9833.578
Total Operating Expenses7,046.2841,895.4081,283.8881,924.914
Operating Income or Loss-6,612.997-1,831.769-1,243.17-1,910.212
Income from Continuing Operations
Total Other Income/Expenses Net3.81-97.696-34.079-73.058
Earnings Before Interest and Taxes-6,612.997-1,831.769-1,243.17-1,910.212
Interest Expense--6.015-2.25-31.544
Income Before Tax-6,609.187-1,929.465-1,277.249-1,983.27
Income Tax Expense----
Minority Interest--238.476-178.288-115.812
Net Income From Continuing Ops-6,609.187-1,929.465-1,277.249-1,983.27
Non-recurring Events
Discontinued Operations---48.918
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-6,598.843-1,869.277-1,214.773-1,770.5
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-6,598.843-1,869.277-1,214.773-1,770.5